[HTML][HTML] Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: should humoral responses be monitored? A position article

J Barrière, M Carles, C Audigier-Valette, D Re… - European Journal of …, 2022 - Elsevier
Taking into account higher risk of severe coronavirus disease 2019 or death among patients
with cancer, as well as impaired immunogenicity after anti-SARS-CoV-2 vaccines, in …

[HTML][HTML] Duration of immunity following full vaccination against SARS-CoV-2: a systematic review

IY Addo, FA Dadzie, SR Okeke, C Boadi… - Archives of Public …, 2022 - Springer
Background As vaccine roll-out continues across the globe as part of the efforts to protect
humanity against SARS-CoV-2, concerns are increasingly shifting to the duration of vaccine …

[HTML][HTML] Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar

H Chemaitelly, P Tang, MR Hasan… - … England Journal of …, 2021 - Mass Medical Soc
Background Waning of vaccine protection against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern …

mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern

RR Goel, MM Painter, SA Apostolidis, D Mathew… - Science, 2021 - science.org
INTRODUCTION Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA
vaccines are highly effective at preventing infection and especially severe disease …

Effectiveness of COVID-19 vaccines against the Omicron (B. 1.1. 529) variant of concern

N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard… - MedRxiv, 2021 - medrxiv.org
Background A rapid increase in cases due to the SARS-CoV-2 Omicron (B. 1.1. 529) variant
in highly vaccinated populations has raised concerns about the effectiveness of current …

[HTML][HTML] Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce

J Keehner, LE Horton, NJ Binkin… - … England Journal of …, 2021 - Mass Medical Soc
Resurgence of Covid-19 in Vaccinated Health Workers From March through July 2021, a
total of 227 health care workers at UCSD, 57% of whom were fully vaccinated, tested …

[HTML][HTML] Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

KB Pouwels, E Pritchard, PC Matthews, N Stoesser… - Nature medicine, 2021 - nature.com
The effectiveness of the BNT162b2 and ChAdOx1 vaccines against new severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections requires continuous re …

[HTML][HTML] Large-scale study of antibody titer decay following BNT162b2 mRNA vaccine or SARS-CoV-2 infection

A Israel, Y Shenhar, I Green, E Merzon, A Golan-Cohen… - Vaccines, 2021 - mdpi.com
Immune protection following either vaccination or infection with SARS-CoV-2 is thought to
decrease over time. We designed a retrospective study, conducted at Leumit Health …

[HTML][HTML] Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant

N Andrews, J Stowe, F Kirsebom, S Toffa… - … England Journal of …, 2022 - Mass Medical Soc
Background A rapid increase in coronavirus disease 2019 (Covid-19) cases due to the
omicron (B. 1.1. 529) variant of severe acute respiratory syndrome coronavirus 2 in highly …

Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK

N Andrews, E Tessier, J Stowe, C Gower, F Kirsebom… - medrxiv, 2021 - medrxiv.org
Background COVID-19 vaccines have been used for 9 months in the UK. Real world data
have demonstrated the vaccines to be highly effective against COVID-19, severe disease …